Mannose-modified erythrocyte membrane-encapsulated chitovanic nanoparticles as a DNA vaccine carrier against reticuloendothelial tissue hyperplasia virus

Mannose-modified erythrocyte membrane-encapsulated chitovanic nanoparticles as a DNA vaccine carrier against reticuloendothelial tissue hyperplasia virus

IntroductionThe erythrocyte membranes used in nanovaccines include high membrane stability, long circulation life, adaptability and extremely good bio compatibility. Nanoparticles encapsulated by erythrocyte membranes are widely used as ideal drug delivery vehicles because of their high drug loading...

Full description

Bibliographic Details
Main Authors: Yangyang Feng, Feng Tang, Sheng Li, Daiyan Wu, Qianqian Liu, Hangyu Li, Xinnan Zhang, Ziwei Liu, Linzi Zhang, Haibo Feng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
reticuloendothelial virus bionic
chitosan
erythrocyte membrane
mannose modification
delivery system
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1066268/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1066268/full

Similar Items